Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of efferocytosis as a novel cancer therapy
Yunxiang Zhou, Yihan Yao, Yongchuan Deng, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis blockade triggered tumor-specific immunity
Wanru Zhuang, Yunfeng Wang, Weidong Nie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 55
Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
Xuefei Zhou, Xiangrui Liu, Leaf Huang
Advanced Functional Materials (2020) Vol. 31, Iss. 5
Open Access | Times Cited: 106
Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications
Haiming Wang, Zifan Liu, Junjie Shao, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 64
The ABCA1-efferocytosis axis: A new strategy to protect against atherosclerosis
Wujun Chen, Li Lü, Jie Wang, et al.
Clinica Chimica Acta (2021) Vol. 518, pp. 1-8
Closed Access | Times Cited: 49
Efferocytosis: An accomplice of cancer immune escape
Hui Qiu, Zhiying Shao, Xin Wen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115540-115540
Open Access | Times Cited: 17
Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits
Yumin Wu, Chunjie Wang, Yifan Yan, et al.
ACS Nano (2023) Vol. 17, Iss. 18, pp. 18089-18102
Closed Access | Times Cited: 15
Overnutrition and Lipotoxicity: Impaired Efferocytosis and Chronic Inflammation as Precursors to Multifaceted Disease Pathogenesis
Vivek Mann, Alamelu Sundaresan, Shishir Shishodia
Biology (2024) Vol. 13, Iss. 4, pp. 241-241
Open Access | Times Cited: 5
Clinical significance of lipid pathway-targeted therapy in breast cancer
Dan Li, Pengcheng Jin, Yiqi Cai, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Efferocytosis-related gene IL33 predicts prognosis and immune response and mediates proliferation and migration in vitro and in vivo of breast cancer
He Xiao, Xi Cheng, Zhun Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Engineered macrophage nanoparticles enhance microwave ablation efficacy in osteosarcoma via targeting the CD47-SIRPα Axis: A novel Biomimetic immunotherapeutic approach
Xiongfa Ji, Xinming Qian, Guowen Luo, et al.
Bioactive Materials (2025) Vol. 47, pp. 248-265
Closed Access
Single-cell transcriptomic analysis reveals efferocytosis signature predicting immunotherapy response in hepatocellular carcinoma
Longhu Li, Guangyao Li, Wangfeng Zhai
Digestive and Liver Disease (2025)
Closed Access
Cholesterol efflux protein, ABCA1, supports anti-cancer functions of myeloid immune cells
Shruti V. Bendre, Yu Wang, Basel Hajyousif, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Dys-regulated phosphatidylserine externalization as a cell intrinsic immune escape mechanism in cancer
Rachael Pulica, Ahmed Aquib, Christopher Varsanyi, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
An imbalance of the IL-33/ST2-AXL-efferocytosis axis induces pregnancy loss through metabolic reprogramming of decidual macrophages
Yan‐Ran Sheng, Wenting Hu, Hui‐Hui Shen, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 24
Combining bulk and scRNA‐seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC
Shaoliang Zhu, Jason Chia‐Hsien Cheng, Mengjie Zou, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 4
Integrating Bulk RNA and Single-Cell Sequencing Data Unveils Efferocytosis Patterns and ceRNA Network in Ischemic Stroke
Jing Yuan, Yu-sha Liao, Tie-chun Zhang, et al.
Translational Stroke Research (2024)
Closed Access | Times Cited: 4
Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis
Zhixin Ma, Yu Sun, Yang Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness
Patrick Fordjour Asare, Eugene Roscioli, P. Hurtado, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 35
Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
Adonis Sfera, Carolina Osorio, Carlos Manuel Zapata Martín del Campo, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 27
The DNA damage response pathway regulates the expression of the immune checkpoint CD47
Lucy Ghantous, Yael Volman, Ruth Hefez, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 10
Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis
David Ngai, Santosh R. Sukka, Ira Tabas
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer
Dorothea Plundrich, Sophia Chikhladze, Stefan Fichtner‐Feigl, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2782-2782
Open Access | Times Cited: 16
Leveraging efferocytosis blockade for improved cancer chemo-immunotherapy through synchronized release of doxorubicin and BMS777607 confined within tailored mesoporous silica nanoparticles
Jingyang Zhang, Fangman Chen, Yuxuan Li, et al.
Nano Today (2023) Vol. 53, pp. 102039-102039
Closed Access | Times Cited: 9
Chemoproteomics-based profiling reveals potential antimalarial mechanism of Celastrol by disrupting spermidine and protein synthesis
Peng Gao, Jianyou Wang, Huan Tang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression
Yu Sun, Wenjun Xiao, Yang Yu, et al.
Experimental Cell Research (2023) Vol. 426, Iss. 2, pp. 113565-113565
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top